Boost for therapeutic polymersPosted on Thursday, May 14th, 2009 in News| Share this article
A Sheffield team led by Dr Giuseppe Battaglia and working closely with companies such as Biocompatibles Ltd, Oxford BioMedica Ltd, GlaxoSmithKline and UCB Pharma, will receive £2.2m to develop polymers as therapeutic delivery agents to target the central nervous system.
Dr Battaglia and co-workers have pioneered the use of polymer vesicles as kinetically stable, controllable delivery agents in gene delivery. The main challenge of this programme will be to carry therapeutic agents across the blood-brain barrier and blood-cerebrospinal fluid barrier.
For more information, please contact Dr Battaglia directly.